According to Zhao et al., SNHG14 is highly expressed in diffuse large B cell lymphoma, and the SNHG14/miR-5590-3p/ZEB1 pathway would enable tumor immune evasion by regulating the immune checkpoint PD-1; targeted inhibition of SNHG14 expression is likely to improve the efficacy of immunotherapy (38). The gene discussed is ZEB1; the disease is neoplasm.